A patient-based medaka alg2 mutant as a model for hypo-N-glycosylation | Citedby Results | Development | The Company of Biologists

Skip to Main Content

Skip Nav Destination

A patient-based medaka alg2 mutant as a model for hypo-N-glycosylation

Development (2021) 148 (11): dev199385.

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Characterizing medaka visual features using a high-throughput optomotor response assay

Risa Suzuki
Jia Zheng Woo
Thomas Thumberger
Gero Hofmann
Joachim Wittbrodt
Tinatini Tavhelidse-Suck
Stephan C.F. Neuhauss

PLOS ONE (2024) 19 (6): e0302092.

ALG2 inhibits the epithelial-to-mesenchymal transition and stemness of ovarian granulosa cells through the Wnt/β-catenin signaling pathway in polycystic ovary syndrome

Qin Zheng
Mulin Liu
Juan Fu

Reproductive Biology (2022) 22 (4): 100706.

Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG)

Sandra Brasil
Mariateresa Allocca
Salvador C. M. Magrinho
Inês Santos
Madalena Raposo
Rita Francisco
Carlota Pascoal
Tiago Martins
Paula A. Videira
Florbela Pereira
Giuseppina Andreotti
Jaak Jaeken
Kristin A. Kantautas
Ethan O. Perlstein
Vanessa dos Reis Ferreira

International Journal of Molecular Sciences (2022) 23 (15): 8725.